Cambium Bio Limited has released a press release.
Response to ASX Appendix 4C Query Letter
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- New CEO Appointed to Accelerate Global Growth
- Chinese patent granted for biomarkers for stem cell therapy
- Re-Released - Appendix 4C - Quarterly
- Progenza patent to grant in Europe
- Regeneus receives R&D tax incentive refund of $2.4m
Later from Cambium Bio
- Directors Provide $2.5M Loan to Extend Funding Runway
- Positive results for Progenza in treating neuropathic pain
- Successful Private Placement
- Investor Presentation
- Offer Booklet
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio